(Q53366519)

13 May 2018

title

BRAF mutations in an Italian cohort of thyroid cancers. (English)

1 reference

13 May 2018

0 references

3

1 reference

13 May 2018

Paolo Beck-Peccoz

7

object named as

Paolo Beck-Peccoz

1 reference

13 May 2018

author name string

Laura Fugazzola

1

1 reference

13 May 2018

Deborah Mannavola

2

1 reference

13 May 2018

Guia Vannucchi

4

1 reference

13 May 2018

Marina Muzza

5

1 reference

13 May 2018

Leonardo Vicentini

6

1 reference

13 May 2018

publication date

1 August 2004

1 reference

13 May 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Clinical Endocrinology

1 reference

13 May 2018

volume

61

1 reference

13 May 2018

page(s)

239-243

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

BRAF mutations in papillary carcinomas of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

BRAF and KRAS mutations in stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

Development of anticancer drugs targeting the MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

BRAF T1796A transversion mutation in various thyroid neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02089.X

10.1111/J.1365-2265.2004.02089.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

15272920

1 reference

13 May 2018